Cargando…
Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease
BACKGROUND: Although many therapeutic strategies for Alzheimer’s disease (AD) have been explored, these strategies are seldom used in the clinic. Therefore, AD therapeutic research is still urgently needed. One major challenge in the field of nanotherapeutics is to increase the selective delivery of...
Autores principales: | Gao, Chunhong, Chu, Xiaoyang, Gong, Wei, Zheng, Jinpeng, Xie, Xiangyang, Wang, Yuli, Yang, Meiyan, Li, Zhiping, Gao, Chunsheng, Yang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7222444/ https://www.ncbi.nlm.nih.gov/pubmed/32404183 http://dx.doi.org/10.1186/s12951-020-00626-1 |
Ejemplares similares
-
Retraction Note: Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease
por: Gao, Chunhong, et al.
Publicado: (2023) -
Polymer Distribution and Mechanism Conversion in Multiple Media of Phase-Separated Controlled-Release Film-Coating
por: Chen, Lu, et al.
Publicado: (2019) -
Neuronal mitochondria-targeted therapy for Alzheimer’s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems
por: Han, Yang, et al.
Publicado: (2020) -
Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery
por: Cui, Lin, et al.
Publicado: (2018) -
Lung-Targeted Delivery of Cepharanthine by an Erythrocyte-Anchoring Strategy for the Treatment of Acute Lung Injury
por: Zheng, Jinpeng, et al.
Publicado: (2022)